MNKD

MannKind Corporation is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. The Company's technologies, Technosphere dry-powder formulations and Dreamboat inhalation devices offer convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. The Company's products are Afrezza (insulin human) Inhalation Powder, and V-Go wearable insulin delivery device. Afrezza (insulin human) Inhalation Powder is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. V-Go wearable insulin delivery device provides continuous subcutaneous infusion of insulin in adults that require insulin.